Infectious Arthritis Overview

Save information for later
Sign Up

Learn About Infectious Arthritis

View Main Condition: Arthritis

What is the definition of Infectious Arthritis?
Infectious arthritis is joint pain, soreness, stiffness and swelling caused by a bacterial, viral, or fungal infection that spreads from another part of the body. Depending on the type of infection, one or more joints may be affected. Certain bacteria can cause a form of Infectious arthritis called reactive arthritis, which appears to be caused by the immune system reacting to bacteria, rather than by the infection itself. In reactive arthritis, joint inflammation develops weeks, months or even years after the infection. Reactive arthritis happens most commonly after infections of the genital and gastrointestinal tracts. To diagnose Infectious arthritis, your health care provider may do tests of your blood, urine, and joint fluid.
What are the alternative names for Infectious Arthritis?
  • Infectious arthritis
  • Septic arthritis
Who are the top Infectious Arthritis Local Doctors?
Daniel Wendling
Elite in Infectious Arthritis
Daniel Wendling
Elite in Infectious Arthritis
Daniel Wendling

CHU Gabriel Montpied

Clermont-ferrand, FR 

Daniel Wendling practices in Clermont-ferrand, France. Mr. Wendling is rated as an Elite expert by MediFind in the treatment of Infectious Arthritis. His top areas of expertise are Arthritis, Ankylosing Spondylitis, Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Osteotomy.

Robert D. Inman
Elite in Infectious Arthritis
Robert D. Inman
Elite in Infectious Arthritis
Robert D. Inman
Toronto, ON, CA 

Robert Inman practices in Toronto, Canada. Mr. Inman is rated as an Elite expert by MediFind in the treatment of Infectious Arthritis. His top areas of expertise are Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), Arthritis, and Reactive Arthritis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Infectious Arthritis
Sakir M. Ahmed
Elite in Infectious Arthritis
Sakir M. Ahmed
Bhubaneshwar, OR, IN 

Sakir Ahmed practices in Bhubaneshwar, India. Ahmed is rated as an Elite expert by MediFind in the treatment of Infectious Arthritis. Their top areas of expertise are Reactive Arthritis, Infectious Arthritis, Septic Arthritis, Endoscopy, and Percutaneous Coronary Intervention (PCI).

View All Doctors
What are the latest Infectious Arthritis Clinical Trials?
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Enrollment Status: Recruiting
Publish Date: June 22, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable

Summary: Differentiating between septic arthritis and other causes of joint inflammation in pediatric patients is challenging and of the utmost importance because septic arthritis requires surgical debridement as part of the treatment regimen. The current gold standard to diagnose septic arthritis in children is a positive synovial fluid culture; however, joint cultures may take several days to return. If ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Comparing Optimal Step-down Therapy for Children With Invasive MRSA Trimethoprim-Sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Comparing Optimal Step-down Therapy for Children With Invasive MRSA Trimethoprim-Sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Enrollment Status: Recruiting
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 4

Summary: The goal of this clinical trial is to learn if trimethoprim-sulfamethoxazole (TMP-SMX) works to treat invasive infections due to methicillin-resistant Staphylococcus aureus (MRSA) in children. It will also learn about the safety of TMP-SMX in the treatment of children with invasive MRSA infections. The main questions it aims to answer are: -Is TMP-SMX effective at successfully treating children wi...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 13, 2022
Published By: Genetic and Rare Diseases Informnation Center